2. Gene
  3. AR - androgen receptor Gene

AR - androgen receptor Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：雄激素受体

种属: Macaca fascicularis

同用名: NR3C4

基因 ID: 102117720 | 基因类型: protein coding

关于 AR

Primary_assembly X: 61,251,587-61,415,611 forward strand.Macaca_fascicularis_6.0:CM021959.1

This gene has 2 transcripts (splice variants), 276 orthologues and 7 paralogues.

AR 基因产物(2)

mRNA Protein Name
XM_005593810.3 XP_005593867.1 androgen receptor isoform X1
XM_045384269.1 XP_045240204.1 androgen receptor isoform X2

AR 蛋白结构

Androgen_recep

Androgen_recep: pfam02166 (5 - 431)

NR_DBD_AR

NR_DBD_AR: cd07173 (529 - 610)

NR_LBD_AR

NR_LBD_AR: cd07073 (647 - 892)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 895 a.a.
蛋白主名 其他名称

androgen receptor

Dihydrotestosterone receptor

Nuclear receptor subfamily 3 group C member 4

相关产品

Approval
生物活性分子 (59)
目录号 产品名 作用方式
纯度 是否罕见病
HY-70002 Enzalutamide 99.96% 否
HY-13715 Norepinephrine 99.33% 否
HY-B0573 Propranolol hydrochloride Antagonist 99.97% 是
HY-Y1269 Ammonium chloride, AR, 99.5% Inhibitor 99.60% 是
HY-111372 Finerenone Antagonist 99.92% 否
HY-N0378 D-Mannitol 99.93% 是
HY-13715A Norepinephrine hydrochloride 99.95% 是
HY-B0573B Propranolol Antagonist 99.87% 是
HY-N0092 Inosine Agonist 99.61% 是
HY-16060 Apalutamide Antagonist 99.97% 否
HY-16985 Darolutamide Antagonist 99.28% 否
HY-10064 Ticagrelor Antagonist 99.92% 是
HY-14249 Bicalutamide 99.85% 否
HY-13715B Norepinephrine bitartrate monohydrate 99.75% 否
HY-13613 Dutasteride 99.83% 是
HY-12715 Yohimbine Antagonist 99.91% 是
HY-B1037 Salbutamol 99.92% 是
HY-15746 Dobutamine hydrochloride Agonist 99.91% 是
HY-19638A Cangrelor tetrasodium Antagonist 99.93% 否
HY-14300A Vilanterol trifenatate Agonist 99.61% 否
HY-B0659A Brimonidine tartrate Agonist 99.14% 是
HY-17042A Cetirizine dihydrochloride Antagonist 99.53% 是
HY-17627 Avacopan Inhibitor 99.75% 是
HY-17497A Acebutolol hydrochloride Antagonist 99.97% 否
HY-14300 Vilanterol Agonist 99.30% 否
HY-B1114 Gliquidone 99.52% 否
HY-B0111 Drospirenone Agonist 98.45% 否
HY-10122 Silodosin Antagonist 99.85% 是
HY-N0138 Theobromine Inhibitor 99.78% 否
HY-B0659 Brimonidine Agonist 99.99% 是
HY-A0295 (R)-Propranolol hydrochloride Antagonist 99.36% 否
HY-Y0537 Potassium chloride, AR, 99.5% ≥99.0% 否
HY-14301 Olodaterol Agonist 98.48% 否
HY-17042 Cetirizine Antagonist 99.51% 是
HY-12798B Netarsudil hydrochloride Inhibitor 99.77% 否
HY-14301A Olodaterol hydrochloride Agonist 98.87% 否
HY-12798A Netarsudil dimesylate 99.56% 否
HY-B0004 Doxofylline 99.65% 是
HY-B1276 Metaproterenol hemisulfate Agonist 99.86% 否
HY-B1486 Oxprenolol hydrochloride Antagonist 99.86% 否
HY-14806A Teneligliptin hydrobromide Inhibitor 99.99% 否
HY-16216 Gabapentin enacarbil Inhibitor ≥95.0% 是
HY-B1016 Trapidil Inhibitor ≥98.0% 否
HY-B0010A Arformoterol Agonist 99.96% 否
HY-U00205 Dopexamine hydrochloride Agonist 99.71% 否
HY-15746A Dobutamine Agonist / 否
HY-15746B Dobutamine tartrate Agonist / 否
HY-19638 Cangrelor Antagonist / 否
HY-13613R Dutasteride (Standard) / 否
HY-13715C Norepinephrine tartrate / 否
HY-13715R Norepinephrine (Standard) / 否
HY-17497 Acebutolol Antagonist / 否
HY-B0010D Arformoterol tartrate Agonist / 否
HY-B0659S Brimonidine-d4 Agonist / 否
HY-B1001 Todralazine Inhibitor / 否
HY-B1037R Salbutamol (Standard) / 否
HY-B1486A Oxprenolol Antagonist / 否
HY-B0010E Arformoterol maleate Agonist / 否
HY-U00244 Benzquinamide Inhibitor / 否
Clinical Phase
生物活性分子 (28)
目录号 产品名 作用方式
纯度 Phase
HY-15758 3,3'-Diindolylmethane 99.93% Phase 4
HY-10211 Tanespimycin 99.07% Phase 3
HY-12365 Namodenoson Agonist 99.75% Phase 3
HY-13591 Piclidenoson 99.28% Phase 3
HY-108449 Acoltremon Agonist 99.90% Phase 3
HY-50289 Sorbinil Inhibitor 99.85% Phase 3
HY-Y0261A Ammonium sulphate,≥99.0%,AR 99.3% Phase 3
HY-101479 Iclaprim Inhibitor 99.49% Phase 3
HY-15314 Ranirestat Inhibitor 96.10% Phase 3
HY-138641 Bavdegalutamide Inhibitor 99.64% Phase 2
HY-111784 Inobrodib Inhibitor 99.53% Phase 2
HY-129393 Etrumadenant Antagonist 99.79% Phase 2
HY-101978 Ciforadenant Antagonist 99.85% Phase 2
HY-101980 Imaradenant Antagonist 99.68% Phase 2
HY-153342 Luxdegalutamide Degrader 98.94% Phase 2
HY-115282A JNJ-63576253 Antagonist 99.22% Phase 2
HY-15996 Seviteronel 99.83% Phase 2
HY-123875A Ralaniten triacetate Inhibitor 98.79% Phase 2
HY-109139 Taminadenant Antagonist 99.84% Phase 2
HY-11027 MK-0773 Inhibitor 98.39% Phase 2
HY-100186 GSK-2881078 Modulator 99.74% Phase 2
HY-108235A Lanicemine dihydrochloride Antagonist 99.94% Phase 2
HY-19436 Solabegron Agonist 99.89% Phase 2
HY-115282 JNJ-63576253 free base Antagonist / Phase 2
HY-U00371 AR-08 Agonist / Phase 2
HY-16079 AZD3514 Inhibitor 99.00% Phase 1
HY-125639 (rac)-AR-13503 Inhibitor / Phase 1
HY-N2037 Higenamine Agonist / Phase 1
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 Phase
HY-P99551 Tosatoxumab 95.00% Phase 3
HY-P99450 Avdoralimab Inhibitor 95.16% Phase 2
Pre-clinical Phase
生物活性分子 (387)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-13248 AR-C155858 Inhibitor 99.62% 否
HY-145388 AU-15330 99.57% 否
HY-134923 CA77.1 Inducer 99.98% 否
HY-101106 AR7 Antagonist 98.85% 否
HY-19532 ZM241385 Antagonist 99.26% 否
HY-106178 PMX-53 Antagonist 98.60% 否
HY-10512 AR-A014418 Inhibitor 99.14% 否
HY-W187305 MASM7 99.56% 否
HY-N0790 Lupeol ≥98.0% 否
HY-138161 JR14a Antagonist 98.52% 否
HY-W015061 Phenylacetylglycine 99.63% 否
HY-116522 AR420626 98.58% 否
HY-110136A PMX 205 Trifluoroacetate Antagonist 98.02% 否
HY-130492 ARCC-4 Inhibitor 99.90% 否
HY-135794 11-Ketodihydrotestosterone Agonist 98.03% 否
HY-N1943 Ailanthone Inhibitor 99.76% 否
HY-N0236 Corylin Inhibitor 99.97% 否
HY-12111 BMS-564929 Agonist 98.17% 否
HY-N0166 Gramine 99.63% 否
HY-145479 PROTAC AR-V7 degrader-1 Inhibitor 99.34% 否
HY-136242 UT-34 Antagonist 98.61% 否
HY-19334 L755507 Agonist 98.33% 否
HY-116501 VPC-14449 Inhibitor 99.71% 否
HY-114936 Piericidin A Inhibitor ≥99.0% 否
HY-109070 Ralaniten Antagonist 99.78% 否
HY-103169 SCH442416 Antagonist 99.68% 否
HY-148141 JPE-1375 Antagonist 99.94% 否
HY-N0528 Linarin Inhibitor 98.00% 否
HY-110126 AR-C118925XX Antagonist ≥99.0% 否
HY-P1345A TLQP-21 TFA Agonist 99.90% 否
HY-100348 EPI-001 98.87% 否
HY-10547 OSU-03012 98.88% 否
HY-121251 BI-167107 Agonist 99.98% 否
HY-108250 (R)-Bicalutamide Antagonist 99.91% 否
HY-148771 MTX-23 99.90% 否
HY-150102 EPI-7170 Antagonist 95.26% 否
HY-16758 Verosudil Inhibitor 99.18% 否
HY-101986 BIIE-0246 Antagonist 99.10% 否
HY-123012 Lubabegron Modulator 98.21% 否
HY-12798C AR-13503 96.74% 否
HY-19319 MI-136 99.71% 否
HY-112895 UT-155 Antagonist 99.55% 否
HY-12023 GTx-007 Modulator 99.67% 否
HY-133045 VHL Ligand 8 99.71% 否
HY-N2908 Atraric acid 99.94% 否
HY-19337 Ketodarolutamide Antagonist 98.68% 否
HY-132292 ARD-2128 Inhibitor 99.40% 否
HY-13265 AR-42 Inducer 98.69% 是
HY-112052 Aminomalonic acid ≥98.0% 否
HY-P0298A [Des-Arg9]-Bradykinin acetate Agonist 99.95% 否
HY-145709 Ar-V7-IN-1 Inhibitor 99.88% 否
HY-70002B Enzalutamide carboxylic acid 98.11% 否
HY-15564 AR 231453 Agonist 99.70% 否
HY-133020 ARD-266 Inhibitor 99.66% 否
HY-116214 Cyprodinil 99.36% 否
HY-112257 S-23 Modulator 99.93% 否
HY-120006A (rel)-AR234960 Agonist 99.42% 否
HY-124292 Honokiol DCA Inhibitor 95.21% 否
HY-122611A CSRM617 hydrochloride 99.97% 否
HY-130992 Androgen receptor antagonist 1 Antagonist 99.71% 否
HY-B0845 Prochloraz 99.77% 否
HY-114402 ARD-69 Antagonist 99.75% 否
HY-139644 MIPS521 Agonist 99.65% 否
HY-101986A BIIE-0246 hydrochloride Antagonist ≥99.0% 否
HY-110060 NDT 9513727 Antagonist 99.10% 否
HY-111151 AR-9281 Inhibitor 99.43% 否
HY-139659 ARD-61 99.68% 否
HY-16060S Apalutamide-d4 Antagonist ≥99.0% 否
HY-19687 Zopolrestat Inhibitor 99.94% 否
HY-W110883 Xylenol orange tetrasodium salt, IND ≥95.0% 否
HY-18776 A2AR-agonist-1 Agonist 99.05% 否
HY-102076 0990CL Inhibitor ≥98.0% 否
HY-103180 2'-MeCCPA Agonist 99.79% 否
HY-111809 N6-Ethyladenosine Agonist 99.53% 否
HY-120018 VPC-13566 Inhibitor 99.87% 否
HY-153152 DPTN dihydrochloride Antagonist 98.66% 否
HY-W093399 Ammonium bicarbonate,AR,99% ≥99.0% 否
HY-110012 SCH-202676 hydrobromide Modulator 96.81% 否
HY-101039A AR-M 1000390 hydrochloride Agonist 99.05% 否
HY-101854 N6-(2-Phenylethyl)adenosine Agonist 99.41% 否
HY-103190 MRS1220 Antagonist 99.50% 否
HY-112256 ACP-105 Modulator 98.99% 否
HY-12122A AR-C102222 hydrochloride Inhibitor 98.80% 否
HY-130845A AR antagonist 1 hydrochloride Antagonist 99.53% 否
HY-N4089 Quercetin 3-gentiobioside Inhibitor 99.92% 否
HY-158101 BMS-986365 Degrader 99.92% 否
HY-111848A PROTAC AR Degrader-4 TFA Inhibitor / 否
HY-133127 AR453588 Activator 99.84% 否
HY-117669 VPC-14228 Inhibitor 99.92% 否
HY-131498 MOCAc-PLGL(Dpa)AR 99.86% 否
HY-14250 PF-998425 Antagonist 98.31% 否
HY-153918 (R)-SKBG-1 Inhibitor 98.03% 否
HY-70002S1 Enzalutamide-d6 Antagonist 99.74% 否
HY-B0031S1 Quetiapine-d4 hemifumarate 99.69% 否
HY-B0573BS Propranolol-d7 Antagonist ≥99.0% 否
HY-B0573S1 Propranolol-d7 (ring-d7) Antagonist 99.38% 否
HY-B0846 Dimethomorph Inhibitor 99.13% 否
HY-B1001A Todralazine hydrochloride Inhibitor 99.87% 否
HY-W013249 Boc-piperazine-benzoic acid 97.42% 否
HY-101300 Cirazoline hydrochloride Agonist 99.65% 否
HY-156111 ARD-1676 Degrader 98.05% 否
HY-111372A (Rac)-Finerenone Antagonist 99.66% 否
HY-103162 ANR94 Antagonist 98.87% 否
HY-134851 HIV-1 inhibitor-6 Inhibitor 98.91% 否
HY-135483A AR-R17779 hydrochloride Agonist ≥99.0% 否
HY-141487 CLP-3094 Inhibitor ≥95.0% 否
HY-149433 BWA-522 Inducer 99.93% 否
HY-N6703 ar-Turmerone Inducer 98.52% 否
HY-N7045 Isosilybin B 99.32% 否
HY-W015061S N-(Phenylacetyl-d5)glycine ≥99.0% 否
HY-111848 PROTAC AR Degrader-4 Inhibitor / 否
HY-101393A CGP 12177 hydrochloride Modulator 99.57% 否
HY-103183 CV1808 Agonist ≥98.0% 否
HY-106954 Upidosin Antagonist 99.58% 否
HY-110136 PMX 205 Antagonist / 否
HY-111145 RD162 Antagonist 99.69% 否
HY-117992 BR103 99.75% 否
HY-119996A AR-C141990 hydrochloride Inhibitor ≥98.0% 否
HY-12715S Yohimbine-13C,d3 Antagonist ≥99.0% 否
HY-130353 Desethylamiodarone hydrochloride ≥99.0% 否
HY-131280 Devaleryl Valsartan Impurity 99.99% 否
HY-131388 ABM-14 98.17% 否
HY-134983 Thalidomide-Piperazine 5-fluoride Inducer 96.47% 否
HY-135732 SK33 Antagonist 99.81% 否
HY-136596 Apalutamide-COOH ≥98.0% 否
HY-14250A (Rac)-PF-998425 Antagonist 99.68% 否
HY-144127 AR antagonist 3 Antagonist 99.96% 否
HY-149862 ARD-2051 Degrader 98.19% 否
HY-151239 ONT-993 Inhibitor 95.13% 否
HY-151596 MAO-A/5-HT2AR-IN-1 Inhibitor 99.71% 否
HY-151604 Transketolase-IN-3 Inhibitor 98.52% 否
HY-16060S1 Apalutamide-d3 / 否
HY-17042S Cetirizine-d4 Antagonist ≥98.0% 否
HY-B1486S Oxprenolol-d7 hydrochloride Antagonist 98.25% 否
HY-B1866 Linuron Antagonist 99.94% 否
HY-N0138S1 Theobromine-d3 Inhibitor 99.78% 否
HY-N2407R 1,4-Butanediamine (Standard) / 否
HY-N2673 5-Heptadecylresorcinol Activator ≥98.0% 否
HY-N4232 Clematichinenoside AR Inducer ≥99.0% 否
HY-P0298 [Des-Arg9]-Bradykinin Agonist / 否
HY-P5213 Vasopressin Dimer (parallel) (TFA) Activator 99.55% 否
HY-W109613 Methyl dehydroabietate Inhibitor 99.89% 否
HY-W110794 Crystal violet indicator (0.0-2.0)(C.I. 42555), AR / 否
HY-19346 AR-13324 analog mesylate ≥98.0% 否
HY-W060074 1-Acetyl-β-carboline / 否
HY-W653723 N-Nitrosodicyclohexylamine Antagonist ≥99.0% 否
HY-130845 AR antagonist 1 / 否
HY-101514 β3-AR agonist 1 Agonist / 否
HY-125839 OP-3633 Antagonist / 否
HY-133127A AR453588 hydrochloride Activator / 否
HY-130353S Desethyl Amiodarone-d4 hydrochloride / 否
HY-14249S Bicalutamide-d4 / 否
HY-N0138S Theobromine-d6 Inhibitor / 否
HY-100348R EPI-001 (Standard) / 否
HY-100554 BMY 7378 / 否
HY-100661 Cetirizine Impurity D Antagonist / 否
HY-100665R Dehydroaripiprazole (Standard) Agonist / 否
HY-100665S Dehydroaripiprazole-d8 Agonist / 否
HY-101986C BIIE-0246 dihydrochloride Antagonist / 否
HY-10273 Atecegatran metoxil Inhibitor / 否
HY-103177 PSB-10 hydrochloride Inhibitor / 否
HY-103203 ST91 Agonist 99.75% 否
HY-103245 Cl-4AS-1 Agonist / 否
HY-103246 TFM-4AS-1 / 否
HY-10512S AR-A014418-d3 Inhibitor / 否
HY-108633 BYK 49187 Inhibitor / 否
HY-108665 AR-C66096 tetrasodium / 否
HY-110202 MRS5698 Agonist / 否
HY-112006 (S)-ar-Curcumene / 否
HY-113430 5-n-Heneicosylresorcinol Inhibitor / 否
HY-113575 Dehydroaripiprazole hydrochloride Agonist / 否
HY-113781 Ractopamine Agonist / 否
HY-115940 Aldose reductase-IN-2 Inhibitor / 否
HY-115977 Aldose reductase-IN-3 Inhibitor / 否
HY-116042 FSCPX Antagonist 99.72% 否
HY-116214R Cyprodinil (Standard) / 否
HY-116214S Cyprodinil-d5 / 否
HY-116214S1 Cyprodinil-13C6 / 否
HY-117239 SB-206606 Agonist / 否
HY-117953 RU 59063 Inhibitor / 否
HY-119806 TMPPAA Agonist / 否
HY-119993 AR03 Inhibitor / 否
HY-119996 AR-C141990 / 否
HY-120208 MK204 Inhibitor / 否
HY-120652 A3AR antagonist 3 Antagonist / 否
HY-12099 A3AR antagonist 2 Antagonist / 否
HY-122611 CSRM617 / 否
HY-122917 Danshenol A Inhibitor / 否
HY-122963 Danshenol B / 否
HY-123012A Lubabegron fumarate Antagonist / 否
HY-123308 VPC13163 Inhibitor / 否
HY-123310 JNJ-26146900 Antagonist / 否
HY-124270 Sibenadet hydrochloride Agonist / 否
HY-125065 MK-4541 / 否
HY-128934 Antitumor agent-2 / 否
HY-130353R Desethylamiodarone hydrochloride (Standard) / 否
HY-131272 Febuxostat dicarboxylic acid impurity 98.76% 否
HY-131279 Olmesartan ethyl ester / 否
HY-133044 Boc-Pip-alkyne-Ph-COOH / 否
HY-133046 VHL Ligand-Linker Conjugates 17 / 否
HY-133776 Rivastigmine carbamate impurity Inhibitor 99.98% 否
HY-133862 SCH-202676 / 否
HY-135794S 11-Ketodihydrotestosterone-d3 Agonist / 否
HY-13613S Dutasteride-13C6 / 否
HY-13715S (Rac)-Norepinephrine-d3 formate / 否
HY-139104 Thailanstatin D / 否
HY-139694 hA3AR agonist 1 Agonist / 否
HY-139970 VPC-13789 Inhibitor / 否
HY-141865 Adenosine receptor antagonist 1 Antagonist / 否
HY-142923 AR antagonist 2 Antagonist / 否
HY-14300AS Vilanterol-d4 trifenatate Agonist / 否
HY-143535 HG122 / 否
HY-144115 A1AR antagonist 1 Antagonist / 否
HY-144116 A1AR antagonist 2 Antagonist / 否
HY-144672 A2A receptor antagonist 2 Antagonist / 否
HY-145308 Heterobivalent ligand-1 / 否
HY-145406 IHCH-3064 Inhibitor / 否
HY-145698 UCSF678 Agonist / 否
HY-145699 UCSF686 / 否
HY-145706 A2A/A1 AR antagonist-1 Antagonist / 否
HY-145862 5-HT6/5-HT2AR antagonist-1 Agonist / 否
HY-146026 Androgen receptor antagonist 3 Antagonist / 否
HY-146027 Androgen receptor antagonist 4 Antagonist / 否
HY-146397 TD-802 Inhibitor / 否
HY-146456 A1AR antagonist 3 Antagonist / 否
HY-146457 A3AR antagonist 1 Antagonist / 否
HY-146478 A1/A3 AR antagonist 1 Antagonist / 否
HY-146479 A1/A3 AR antagonist 2 / 否
HY-146494 Androgen receptor antagonist 5 Antagonist / 否
HY-146979 hA2A/hCA XII modulator 1 / 否
HY-147100 α1A-AR Degrader 9c Inhibitor / 否
HY-147261 B026 Inhibitor / 否
HY-147291 VPC-70063 / 否
HY-147541 A2A/A3 AR antagonist-1 Antagonist / 否
HY-147543 A1AR antagonist 4 Antagonist / 否
HY-147544 A1AR antagonist 5 Antagonist / 否
HY-147545 A1AR antagonist 6 Antagonist / 否
HY-147585 C5aR-IN-1 / 否
HY-147586 C5aR-IN-2 / 否
HY-147587 C5aR-IN-3 / 否
HY-147706 AR524 / 否
HY-147875 Aldose reductase-IN-6 Inhibitor / 否
HY-147907 Adenosine receptor inhibitor 1 Inhibitor / 否
HY-147908 Adenosine receptor inhibitor 2 Inhibitor / 否
HY-148252 ADRA1D receptor antagonist 1 free base Antagonist / 否
HY-148361 Fluorogen binding modulator-1 / 否
HY-148524 β2AR/M-receptor agonist-1 / 否
HY-148525 PF-4348235 / 否
HY-148526 β2AR/M3-receptor agonist-1 Agonist / 否
HY-148533 β2AR agonist /M-receptor antagonist-1 / 否
HY-148777 A031 Degrader / 否
HY-14897 Rezatomidine Agonist / 否
HY-149434 PROTAC AR-NTD degrader 1 Inducer / 否
HY-149727 β2AR agonist 2 Agonist / 否
HY-149728 β2AR agonist 3 Agonist / 否
HY-149914 WCA-814 Degrader / 否
HY-149916 A2AR-antagonist-1 Antagonist / 否
HY-150025 (4aS,8aR)-NPD-001 / 否
HY-15011 L-372662 Antagonist 98.70% 否
HY-151231 6-Hydroxyluteolin Inhibitor / 否
HY-151266 AR antagonist 4 Antagonist / 否
HY-151899 A3AR modulator 1 Agonist / 否
HY-152524 Androgen receptor antagonist 7 Antagonist / 否
HY-153333 A1/A3 AR antagonist 3 Antagonist / 否
HY-153519 WWL0245 Inhibitor / 否
HY-155183 A3AR agonist 1 Agonist / 否
HY-155184 A3AR agonist 2 Agonist / 否
HY-155543 Anticancer agent 135 Antagonist / 否
HY-155666 YXG-158 Degrader / 否
HY-155772 LUF7690 / 否
HY-156863 GRK2 Inhibitor 2 Inhibitor / 否
HY-156983 MRS 5980 / 否
HY-157425 5-HT2CR agonist 1 Agonist / 否
HY-157455 AR antagonist 5 / 否
HY-157491 K2-B4-5e Degrader / 否
HY-157796 β2AR agonist 4 Agonist / 否
HY-157916 ARP / 否
HY-157918 Carboxy-EG6-hexadecanethiol / 否
HY-158057 A2AR/A2BR antagonist 1 Antagonist / 否
HY-158113 CBPD-409 Degrader / 否
HY-158179 A3AR agonist 3 Agonist / 否
HY-158180 A3AR agonist 4 Agonist / 否
HY-158181 A3AR agonist 5 Agonist / 否
HY-160020 ET516 Inhibitor / 否
HY-160262 AR/BET protein degrader-1 Degrader / 否
HY-160547 PROTAC AR Degrader-5 Inhibitor / 否
HY-16060S2 Apalutamide-13C,d3 Antagonist / 否
HY-160692 AR antagonist 7 Antagonist / 否
HY-161369 CBPD-268 Degrader / 否
HY-161409 SC912 / 否
HY-162083 CB2R/5-HT1AR agonist 1 Agonist / 否
HY-162241 SJH1-62B Degrader / 否
HY-162325 WJ-39 / 否
HY-162412 PROTAC AR/AR-V7 degrader-1 / 否
HY-163340 GA32 Inhibitor / 否
HY-163363 β-AR antagonist 2 Antagonist / 否
HY-163378 C5aR1 antagonist 1 Antagonist / 否
HY-163379 C5aR1 antagonist 2 Antagonist / 否
HY-163485 AR antagonist 8 Inhibitor / 否
HY-163510 AR/AR-V7-IN-1 Inhibitor / 否
HY-17042AS1 Cetirizine-d8 dihydrochloride Antagonist / 否
HY-17042S1 Cetirizine-d8 Antagonist 98.37% 否
HY-17497S Acebutolol-d7 Antagonist / 否
HY-70002S Deutenzalutamide 99.81% 否
HY-78542S Deshydroxyethoxy Ticagrelor-d7 / 否
HY-90009D cis-ent-Tadalafil Inhibitor / 否
HY-B0010AS Formoterol-d3 Agonist / 否
HY-B0031S3 Quetiapine-d8 hemifumarate / 否
HY-B0076S Bisoprolol-d7 hemifumarate Inhibitor / 否
HY-B0573S Propranolol-d7 hydrochloride Antagonist 98.02% 否
HY-B0846S Dimethomorph-d8 / 否
HY-B1114S Gliquidone-d6 / 否
HY-B1276A Metaproterenol Agonist / 否
HY-B1486AS Oxprenolol-d7 Antagonist / 否
HY-B1562 Bopindolol / 否
HY-B1562B Bopindolol (malonate) / 否
HY-B1562C Bopindolol fumarate / 否
HY-D1379 Azophloxine / 否
HY-D1606 BODIPY FL prazosin Inhibitor / 否
HY-N0092S Inosine-2,8-d2 Agonist / 否
HY-N0092S1 Inosine-13C / 否
HY-N0166R Gramine (Standard) / 否
HY-N10906 (4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one / 否
HY-N11163 (Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate / 否
HY-N3716 Dehydroglyasperin D Inhibitor / 否
HY-N6703S ar-Turmerone-d3 Inducer / 否
HY-N6883 6-Methoxytricin Inhibitor / 否
HY-N7962 Cornoside Inhibitor / 否
HY-N9917 Galloylalbiflorin Antagonist / 否
HY-P1129 AR-M1896 Agonist / 否
HY-P1345 TLQP-21 Agonist / 否
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist / 否
HY-P3477 Mca-PLA-Nva-Dap(Dnp)-AR-NH2 / 否
HY-P5010 (D-Arg8)-Inotocin Antagonist / 否
HY-P5214 Vasopressin Dimer (anti-parallel) (TFA) Activator / 否
HY-R01656 hsa-miR-548ar-3p mimic / 否
HY-R01656A hsa-miR-548ar-3p agomir / 否
HY-R01657 hsa-miR-548ar-5p mimic / 否
HY-R01657A hsa-miR-548ar-5p agomir / 否
HY-RI01656 hsa-miR-548ar-3p inhibitor / 否
HY-RI01656A hsa-miR-548ar-3p antagomir / 否
HY-RI01657 hsa-miR-548ar-5p inhibitor / 否
HY-RI01657A hsa-miR-548ar-5p antagomir / 否
HY-RS00883 AR Human Pre-designed siRNA Set A / 否
HY-RS00884 Ar Mouse Pre-designed siRNA Set A / 否
HY-RS00885 Ar Rat Pre-designed siRNA Set A / 否
HY-RS01744 C3AR1 Human Pre-designed siRNA Set A / 否
HY-RS01750 C5AR1 Human Pre-designed siRNA Set A / 否
HY-RS01751 C5AR2 Human Pre-designed siRNA Set A / 否
HY-U00244A Benzquinamide hydrochloride Inhibitor / 否
HY-W140282 Angiotensin II antipeptide Inhibitor / 否
HY-W471937 α1B-AR antagonist 1 Antagonist / 否
HY-Y0261AS Ammonium sulphate-d8 / 否
HY-Y0261AS1 Ammonium sulphate,≥99.0%,AR-N152 ≥98.0% 否
HY-Y0978S2 Boc-Glycine-2-13C Antagonist / 否
HY-10122S Silodosin-d4 Antagonist / 否
HY-101479S Iclaprim-d6 Inhibitor / 否
HY-101977B (3aR)-Selitrectinib Inhibitor / 否
HY-103163 (±)-5'-Chloro-5'-deoxy-ENBA Agonist / 否
HY-111206 β3-AR agonist 3 Agonist / 否
HY-111372S Finerenone-d3 / 否
HY-116379 RS-100329 Antagonist / 否
HY-12122 AR-C102222 Inhibitor / 否
HY-13613S2 Dutasteride-13C,15N,d / 否
HY-14249S1 Bicalutamide-d5 / 否
HY-154959A (9R,12aR)-AZD4747 98.90% 否
HY-155467 MRS7935 Modulator / 否
HY-156084 LL-K9-3 / 否
HY-15746S (rac)-Dobutamine-d4 hydrochloride Agonist / 否
HY-15746S1 (rac)-Dobutamine-d6 hydrochloride Agonist / 否
HY-16060S3 Apalutamide-d7 Antagonist / 否
HY-160680 AR antagonist 6 Inhibitor / 否
HY-19532S ZM241385-d7 Antagonist / 否
HY-400766 BWA-522 intermediate-2 99.87% 否
HY-401056 BWA-522 intermediate-3 / 否
HY-A0052S (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 / 否
HY-B1276S Metaproterenol-d7 hemisulfate Agonist / 否
HY-D0011A Bromophenol red (sultone form) / 否
HY-N0092S3 Inosine-13C10,15N4 Agonist / 否
HY-N0092S4 Inosine-13C3 / 否
HY-N12358 Isogermafurenolide / 否
HY-W110146 (3aS,4S,6aR)-Biotin-PEG4-Alkyne / 否
HY-W877989 BWA-522 intermediate-1 99.27% 否
HY-107018 AR-A 2 Antagonist / 否
HY-118678 MRS1186 Antagonist / 否
HY-120090 MRS1177 Antagonist / 否
HY-U00391 β3-AR agonist 2 Agonist / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens AR NCBI NCBI:367
Canis familiaris AR NCBI NCBI:403588
Canis lupus familiaris AR NCBI
Mus musculus AR NCBI NCBI:11835
Susscrofa domestica AR NCBI
Leporidae AR NCBI
Rattus norvegicus AR NCBI NCBI:24208
Macaca mulatta AR NCBI NCBI:574293
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z